Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis

Journal of Clinical Microbiology

Volumn 45, Issue 12, 2007, Pages 4064-4066

  Palaci, Moises ^a   Dietze, Reynaldo ^a   Hadad, David Jamil ^a   Ribeiro, Fabiola Karla Corrêa ^a   Peres, Renata Lyrio ^a   Vinhas, Solange Alves ^a   Maciel, Ethel Leonor Noia ^a   Dettoni, Valdério Do Valle ^a   Horter, Libby ^b   Boom, W Henry ^b   Johnson, John L ^b   Eisenach, Kathleen D ^c  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL COUNT; BACTERIUM CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG CAVITATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SCREENING TEST; SPUTUM CULTURE; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TUBERCULOSIS, PULMONARY;

BACTERIA (MICROORGANISMS);

EID: 37249009129     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01780-07     Document Type: Article

References (19)

1. Andreu, J., J. Caceres, E. Pallisa, and M. Martinez-Rodriguez. 2004. Radiological manifestations of pulmonary tuberculosis. Eur. J. Radiol. 51:139-149.
2. Benator, D., M. Bhattacharya, L. Bozeman, W. Burman, A. Cantazaro, R. Chaisson, F. Gordin, C. R. Horsburgh, J. Horton, A. Khan, C. Lahart, B. Metchock, C. Pachucki, L. Stanton, A. Vernon, M. E. Villarino, Y. C. Wang, M. Weiner, and S. Weis. 2002. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet 360:528-534.
3. Canetti, G. 1955. The tubercle bacillus in the pulmonary lesion of man: histobacteriology and its bearing on the therapy of pulmonary tuberculosis. Springer Verlag, New York, NY.
4. Canetti, G. 1965. Present aspects of bacterial resistance in tuberculosis. Am. Rev. Respir. Dis. 92:687-703.
5. Dietze, R., L. Teixeira, L. M. Rocha, M. Palaci, J. L. Johnson, C. Wells, L. Rose, K. Eisenach, and J. J. Ellner. 2001. Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis. Antimicrob. Agents Chemother. 45:1972-1976.
6. Donald, P. R., F. A. Sirgel, F. J. Botha, H. I. Seifart, D. P. Parkin, M. L. Vandenplas, B. W. Van de Wal, J. S. Maritz, and D. A. Mitchison. 1997. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 156:895-900.
7. Epstein, M. D., N. W. Schluger, A. L. Davidow, S. Bonk, W. N. Rom, and B. Hanna. 1998. Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest 113:379-386.
8. Falk, A., J. B. O'Connor, and P. C. Pratt. 1969. Classification of pulmonary tuberculosis, p. 68-76. In A. Falk, J. B. O'Connor, P. C. Pratt, J. A. Webb, J. A. Wier, and E. Wolinsky (ed.), Diagnosis standards and classification of tuberculosis, vol. 12. National Tuberculosis and Respiratory Disease Association, New York, NY.
9. Gomes, M., R. Saad Junior, and R. Stirbulov. 2003. Pulmonary tuberculosis: relationship between sputum bacilloscopy and radiological lesions. Rev. Inst. Med. Trop. Sao Paulo 45:275-281.
10. Greenbaum, M., B. E. Beyt, and P. R. Murray. 1980. The accuracy of diagnosing pulmonary tuberculosis at a teaching hospital. Am. Rev. Respir. Dis. 121:477-481.
11. Howard, W. L., F. Maresh, E. E. Mueller, S. A. Yanitelli, and G. F. Woodruff. 1949. The role of pulmonary cavitation in the development of bacterial resistance to streptomycin. Am. Rev. Tuberc. 59:391.
12. Matsuoka, S., K. Uchiyama, H. Shima, K. Suzuki, A. Shimura, Y. Sasaki, and F. Yamagishi. 2004. Relationship between CT findings of pulmonary tuberculosis and the number of acid-fast bacilli on sputum smears. Clin. Imaging 28:119-123.
13. Mitchison, D. A. 1993. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am. Rev. Respir. Dis. 147: 1062-1063.
14. Perrin, F. M., S. L. Batt, N. Woodward, T. D. McHugh, M. C. Lipman, and S. H. Gillespie. 2006. Cavitation and mycobacterial load in patients with pulmonary tuberculosis, p. A505. In Program and Abstracts of the American Thoracic Society International Conference 2006. American Thoracic Society International, San Diego, CA.
15. Rathman, G., J. Sillah, P. C. Hill, J. F. Murray, R. Adegbola, T. Corrah, C. Lienhardt, and K. P. MacAdam. 2003. Clinical and radiological presentation of 340 adults with smear-positive tuberculosis in The Gambia. Int. J. Tuberc. Lung Dis. 7:942-947.
16. Wallis, R. S., S. Patil, S. H. Cheon, K. Edmonds, M. Phillips, M. D. Perkins, M. Joloba, A. Namale, J. L. Johnson, L. Teixeira, R. Dietze, S. Siddiqi, R. D. Mugerwa, K. Eisenach, and J. J. Ellner. 1999. Drug tolerance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:2600-2606.
17. Wilcke, J. T., D. S. Askgaard, B. Nybo Jensen, and M. Dossing. 1998. Radiographic spectrum of adult pulmonary tuberculosis in a developed country. Respir. Med. 92:493-497.
18. World Health Organization. 1998. Laboratory services in tuberculosis control. II. Microscopy. Document WHO/TB 98.258. World Health Organization, Geneva, Switzerland.
19. Zierski, M., E. Bek, M. W. Long, and D. E. Snider, Jr. 1980. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment. Am. Rev. Respir. Dis. 122:879-889.